Clinical-genetic characteristics of limb girdle-muscular dystrophy type 2A

Zhurnal Nevrologii i Psihiatrii imeni S.S. Korsakova

Volumn 110, Issue 4, 2010, Pages 79-83

  Dadali, E L ^a   Shchagina, O A ^a   Ryzhkova, O P ^a   Rudenskaya, G E ^a   Fedotov, V P ^a   Poliakov, A V ^a  

^a NONE

Author keywords

CAPN3 gene; DNA diagnostics; Limb girdle muscular dystrophy

Indexed keywords

CALPAIN 3; CALPAIN; CAPN3 PROTEIN, HUMAN; MUSCLE PROTEIN;

ADULT; ANKLE; ARTICLE; CLINICAL ARTICLE; CONTRACTURE; DISEASE DURATION; FAMILY; GASTROCNEMIUS MUSCLE; HUMAN; LIMB GIRDLE MUSCULAR DYSTROPHY; LIMB GIRDLE MUSCULAR DYSTROPHY TYPE 2A; MOLECULAR GENETICS; PELVIC GIRDLE; SHOULDER GIRDLE; SYMPTOM; ADOLESCENT; CHILD; FEMALE; GENE DELETION; GENETICS; MALE; MIDDLE AGED; MUTATION; PATHOPHYSIOLOGY; RUSSIAN FEDERATION;

ADOLESCENT; ADULT; CALPAIN; CHILD; FEMALE; HUMANS; MALE; MIDDLE AGED; MUSCLE PROTEINS; MUSCULAR DYSTROPHIES, LIMB-GIRDLE; MUTATION; RUSSIA; SEQUENCE DELETION; YOUNG ADULT;

EID: 78049398417     PISSN: 19977298     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Angelini C., Nardetto L., Fanin M. et al. Heterogeneous pathogenesis of LGMD2: consequences for therapy. Basic Applied Mycol 2007;17:173-179.
2. Beckmann J. S., Richard I., Hillarie et al. A gene for limb girdle muscular dystrophy maps to chromosome 15 by linkage. C R Acad Sci (Paris) 1991;132:141-148.
3. Balci B., Aurino S., Haliloglu G. et al. Calpain-3 mutations in Turkey. Eur J Pediat 2006;165:293-298.
4. Bushby K. M., Beckman J. S. The limb-girdle muscular dystrophies-proposal for a new nomenclature. Neuromuscular Dis 1995;5:337-343.
5. Canki-Klain N., Milic A., Kovac B. et al. Prevalence of the 550delA mutation in calpainpathy (LGMD2A) in Croatia. Am J Med Genet 2004;125:152-156.
6. Chae J., Minami N., Jin Y. Calpain 3 gene mutations. genetic and clinicopathologic findings in limb-girdle muscular dystrophy. Neuromuscul Disord 2001;6-7:547-55.
7. Chou F.-L., Angelini C., Daentl D. et al. Calpain III mutation analysis of a heterogeneous limb-girdle muscular dystrophy population. Neurology 1999;52:1015-1019.
8. De Paula F., Vainzof M., Passos-Bueno M. R. et al. Clinical variability in calpainopathy: what makes the difference? Eur J Hum Genet 2002;10:825-832.
9. Emery A. E. N. Neuromuscular disorders: clinical and molecular genetics. Chichester (UK): John Wiley and sons 1998;123-156.
10. Fanin M., Nascimbeni A. C., Tasca E., Angelini C. How to tackle the diagnosis of limb-girdle muscular dystrophy 2A. Eur J Hum Genet 2009;17:5: 598-603.
11. Fardeau M., Eymard B., Mignard C. et al. Chromosome 15-linked limbgirdle muscular dystrophy: clinical phenotypes in Renunion Island and French metropolitan communities. Neuromuscl Disord 1996;6:447-453.
12. Ginjaard H. B., Frankhuizen W. S., de Mos M. et al. Classification of limb girdle muscular dystrophy types 1C, 2A and 2B based on protein and/or DNA studies. Neuromuscul Disord 2000;12:731-735.
13. Meznaric-Petrusa M. M. P., Zidar J., Fanin M. et al. Clinical, molecular and genetic features of calpainopathy in Slovenia. Neuromuscular Disord 2002;12:731-734.
14. Pogoda T. V., Krakchmaleva I. N., Lipatova N. A. et al. High incidence of 550delA of calpain3 in LGMD2A from Russia. Hum Mut 2000;15:295-99.
15. Pogue R., Anderson L. V., Pyle A. et al. Strategy for mutation analysis in the autosomal recessive limb-girdle muscular dystrophies. Neuromuscular Disord 2001;11:80-87.
16. Richard I., Broux O., Allamand V. et al. Mutations in the proteolytic enzyme calpain 3 cause limb-girdle muscular dystrophy type 2A. Cell 1995;27:40-44.
17. Richard I., Roudaut C., Saenz A. et al. Calpainopathy-a survey of mutations and polymorphisms. Am J Hum Genet 1999;64:1524-1540.
18. Saenz A., Leturcq F., Cobo A. M. et al. LGMD2A: genotype-phenotype correlations based on a large mutational survey on the calpain 3 gene. Brain 2005;128:4: 732-742.
19. Tidball J. G., Spencer M. J. Calpains and muscular dystrophies. Int J Biochem Cell Biol 2000;32:1-5.
20. Todorova A., Georgieva B., Tournev I. et al. A large deletion and point mutations in the calpain 3 gene (CAPN3) in Bulgarian LGMD2A patients. Neurogenetics 2007;8:225-229.
21. Urtasun N., Saenz A., Roudaut C. et al. Limb-girdle muscular dystrophy in Guipuzcoa (Basque Country, Spain). Brain 1998;121:1735-1747.
22. Zatz M., de Paula F., Starling A., Vainzof M. The 10 autosomal recessive limb-girdle muscular dystrophies. Neuromuscul Disord 2003;13:532-544.